Skip to main content

Pelvic Fracture

0
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Innovation Pharmaceuticals
1 program
Fragility Fractures of the Pelvis (FFP)N/A1 trial
Active Trials
NCT04182776Recruiting420Est. Jun 2026
SI-BONE
SI-BONESANTA CLARA, CA
1 program
iFuse-3D implantN/A1 trial
Active Trials
NCT05367505Recruiting60Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
SI-BONEiFuse-3D implant
Innovation PharmaceuticalsFragility Fractures of the Pelvis (FFP)

Clinical Trials (2)

Total enrollment: 480 patients across 2 trials

NCT05367505SI-BONEiFuse-3D implant

Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis

Start: Jan 2023Est. completion: Dec 202660 patients
N/ARecruiting
NCT04182776Innovation PharmaceuticalsFragility Fractures of the Pelvis (FFP)

Fragility Fractures of the Pelvis (FFP)

Start: Mar 2022Est. completion: Jun 2026420 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 480 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.